(NASDAQ: CARL) Carlsmed's forecast annual revenue growth rate of 40.08% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 8.72%, and it is also forecast to beat the US market's average forecast revenue growth rate of 15.85%.
Carlsmed's revenue in 2026 is $56,438,000.On average, 7 Wall Street analysts forecast CARL's revenue for 2026 to be $2,076,249,258, with the lowest CARL revenue forecast at $1,987,707,931, and the highest CARL revenue forecast at $2,141,846,501. On average, 7 Wall Street analysts forecast CARL's revenue for 2027 to be $2,910,418,927, with the lowest CARL revenue forecast at $2,651,074,666, and the highest CARL revenue forecast at $3,097,179,417.
In 2028, CARL is forecast to generate $4,065,778,579 in revenue, with the lowest revenue forecast at $3,709,655,957 and the highest revenue forecast at $4,358,832,157.